October 18, 2013

Results from the AREDS2 study further established lutein and zeaxanthin as go-to nutrients for eye health. But findings for omega-3s weren't as favorable.

While many in the industry hailed the results, they also pointed to design flaws. Watch this INSIDER exclusive interview with AREDS2 researcher Paul S. Bernstein, professor of ophthalmology and visual sciences, Moran Eye Center, The University of Utah, to learn what he would have changed about the study design. He also gives his expectations for an AREDS3.

Learn more about the study in INSIDER's Report, "AREDS2: A Deep Look" and learn more about other aspects of vision health in INSIDER's Eye Health Immersion Center.

Editor's note: Looking for ingredients to support your next product launch in the Eye Health category? Leading suppliers, including Divis, DSM, Horphag, OmniActives and Valensa, will be at SupplySide West in Las Vegas, Nov. 12 to 16. Click here for the full exhibitor search , or register now .

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like